These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17323134)

  • 1. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28.
    McLean DS; Sabatine MS; Guo W; McCabe CH; Cannon CP
    J Thromb Thrombolysis; 2007 Oct; 24(2):85-91. PubMed ID: 17323134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Lewis BS; Murphy SA; McCabe CH; Braunwald E;
    JAMA; 2005 Sep; 294(10):1224-32. PubMed ID: 16143698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial.
    Verheugt FW; Montalescot G; Sabatine MS; Soulat L; Lambert Y; Lapostolle F; Adgey J; Cannon CP
    J Thromb Thrombolysis; 2007 Jun; 23(3):173-9. PubMed ID: 17160548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis.
    Ahmed S; Michael Gibson C; Cannon CP; Murphy SA; Sabatine MS
    J Thromb Thrombolysis; 2011 May; 31(4):493-500. PubMed ID: 21318582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Ebrahimi R; Dyke C; Mehran R; Manoukian SV; Feit F; Cox DA; Gersh BJ; Ohman EM; White HD; Moses JW; Ware JH; Lincoff AM; Stone GW
    J Am Coll Cardiol; 2009 May; 53(21):1965-72. PubMed ID: 19460609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
    Scirica BM; Sabatine MS; Morrow DA; Gibson CM; Murphy SA; Wiviott SD; Giugliano RP; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2006 Jul; 48(1):37-42. PubMed ID: 16814646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.
    Sabatine MS; McCabe CH; Gibson CM; Cannon CP
    Am Heart J; 2005 Feb; 149(2):227-33. PubMed ID: 15846259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
    De Servi S; Goedicke J; Schirmer A; Widimsky P
    Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study.
    Dudek D; Dziewierz A; Widimsky P; Bolognese L; Goldstein P; Hamm C; Tanguay JF; LeNarz L; Miller DL; Brown E; Ten Berg J; Montalescot G;
    Am Heart J; 2015 Nov; 170(5):1025-1032.e2. PubMed ID: 26542513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
    Harkness JR; Sabatine MS; Braunwald E; Morrow DA; Sloan S; Wiviott SD; Giugliano RP; Antman EM; Cannon CP; Scirica BM
    Am Heart J; 2010 Jan; 159(1):55-62. PubMed ID: 20102867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.
    Biancari F; Airaksinen KE; Lip GY
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):665-675.e4. PubMed ID: 21703636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.